↓ Skip to main content

SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol

Overview of attention for article published in BMC Cancer, October 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol
Published in
BMC Cancer, October 2019
DOI 10.1186/s12885-019-6259-z
Pubmed ID
Authors

Robert Olson, Roel Schlijper, Nick Chng, Quinn Matthews, Marco Arimare, Lindsay Mathews, Fred Hsu, Tanya Berrang, Alexander Louie, Benjamin Mou, Boris Valev, Joanna Laba, David Palma, Devin Schellenberg, Shilo Lefresne

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 19%
Student > Bachelor 7 13%
Researcher 5 9%
Student > Doctoral Student 3 6%
Professor > Associate Professor 3 6%
Other 6 11%
Unknown 20 37%
Readers by discipline Count As %
Medicine and Dentistry 17 31%
Nursing and Health Professions 10 19%
Sports and Recreations 1 2%
Psychology 1 2%
Decision Sciences 1 2%
Other 1 2%
Unknown 23 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2020.
All research outputs
#15,585,448
of 23,170,347 outputs
Outputs from BMC Cancer
#4,174
of 8,404 outputs
Outputs of similar age
#224,419
of 362,574 outputs
Outputs of similar age from BMC Cancer
#69
of 161 outputs
Altmetric has tracked 23,170,347 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,404 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,574 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 161 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.